Considerations for Choosing Soluble Immune Markers to Determine Safety of Novel Vaginal Products

Anna-Ursula Happel1, Aida Sivro2,3, Lenine Liebenberg2,3

  • 1Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.